SCHEMBL845231

SCHEMBL845231

CSCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccnc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
DPP4 P27487 1/20 0.42
PREP P48147 1/20 0.42
FAP Q12884 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
DPP9 Q86TI2 1/20 0.42
VNN1 O95497 1/20 0.41
RHOC P08134 1/20 0.41
RHOA P61586 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
ROCK2 O75116 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NPC1 O15118 2/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872436 0.91 DPP4 (0.43) DPP4PREPFAPDPP8DPP9
SCHEMBL844960 0.91 DPP4 (0.43) DPP4PREPFAPDPP8DPP9
SCHEMBL845297 0.91 RHOC (0.48) DPP4PREPFAPDPP8DPP9
SCHEMBL845591 0.89 HCRTR1 (0.49) HCRTR1HCRTR2RHOCRHOAROCK2
SCHEMBL845475 0.89 ROCK2 (0.44) DPP4PREPFAPDPP8DPP9
SCHEMBL845228 0.86 HCRTR1 (0.49) HCRTR1HCRTR2MEN1KMT2AALDH1A1
SCHEMBL845461 0.86 PREP (0.44) PREPFAPVNN1RHOCRHOA
SCHEMBL845234 0.85 RHOC (0.43) DPP4PREPFAPDPP8DPP9
SCHEMBL845250 0.83 HCRTR1 (0.46) HCRTR1HCRTR2ALDH1A1GAASMN1; SMN2
SCHEMBL10119294 0.82 ITGB3 (0.41) DPP4PREPFAPDPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed